Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenserine tartrate in Alzheimer's disease (randomised double-blind placebo-controlled)
2004-000089-11Phase 3Completed
- Sponsor
- Axonyx
- Start
- Aug 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Phenserine tartrate with Placebo (2 arms). Primary endpoints: Cognitive performance (ADAS-COG) and Cognitive performance (ADAS-COG+). Started Aug 2004; status: completed.
02
Drugs
phenserine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-000089-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000089-11.